Funded Biotechnology Startups
Across these 27 most-recent biotechnology/healthcare rounds, the largest disclosed amount is $165M for Expedition Therapeutics (San Francisco, US) on 2025-…
Across these 27 most-recent biotechnology/healthcare rounds, the largest disclosed amount is $165M for Expedition Therapeutics (San Francisco, US) on 2025-10-09; it sits well above the rest of the disclosed rounds, with the next-highest disclosed figures at $141M (AAVantgarde Bio, Milano, Italy, 2025-11-03) and $101M (NILO Therapeutics, New York, US, 2025-10-08). Disclosed amounts also show a wide spread: the smallest disclosed round is $200K for AccufyDx (Rockville, US) on 2025-09-30, while several seed rounds cluster in the low-single-digit millions (e.g., Gut Brain Axis Therapeutics at $2M on 2025-11-06; Celaid Therapeutics at $4M on 2025-10-11).
The temporal window runs from 2025-09-24 to 2025-11-27, with multiple rounds concentrated in mid-November: several entries land between 2025-11-10 and 2025-11-16 (e.g., Azure Biosystems at an undisclosed amount on 2025-11-10; AAVantgarde Bio at $141M on 2025-11-03; Expedition Therapeutics at $165M on 2025-10-09). Stage/coverage is also mixed: 5 of 27 entries use “Series Unknown” (Captain T Cell, Azure Biosystems, Leukogene Therapeutics, BlueWhale Bio, and Repairon, each labeled Venture - Series Unknown for the first four and undisclosed amount for Repairon), and 7 of 27 are marked “undisclosed” amounts (including LASO Biotech on 2025-11-27 and Huadao Biopharma on 2025-10-14). Geographically, the US appears repeatedly (e.g., Modulight Bio in Boston on 2025-11-12; Gregor Diagnostics in Madison on 2025-11-09), alongside Europe/Asia entries such as AAVantgarde Bio (Italy) and GRIT Biotechnology (Shanghai, Series C $84M on 2025-10-19).
Most recent rounds
27 shownRelated listings
Frequently asked
What is the largest disclosed biotech/healthcare round in this recent set, and how extreme is it versus the other disclosed deals?
Expedition Therapeutics raised $165M on 2025-10-09, which is significantly larger than the next-highest disclosed rounds: AAVantgarde Bio at $141M (2025-11-03) and NILO Therapeutics at $101M (2025-10-08).
How much of the recent activity is concentrated in the tightest date window (mid-November vs. earlier in the range)?
There’s a visible mid-November cluster: multiple rounds fall between 2025-11-10 and 2025-11-16, including Azure Biosystems (undisclosed on 2025-11-10), Leukogene Therapeutics (undisclosed on 2025-11-10), Rion Vet ($15M on 2025-11-16), and Oncolab ($680K on 2025-11-14).
Are there notable outliers on the low end of disclosed funding amounts?
Yes. AccufyDx is the smallest disclosed round at $200K on 2025-09-30, far below other disclosed seed/early figures like Gregor Diagnostics ($240K on 2025-11-09) and Gut Brain Axis Therapeutics ($2M on 2025-11-06).
What stage mix dominates the list, and how often do stages or amounts remain unspecified?
Seed shows up repeatedly (e.g., Oncolab at $680K on 2025-11-14; Modulight Bio at $12M on 2025-11-12; Gut Brain Axis Therapeutics at $2M on 2025-11-06). At the same time, “Series Unknown” appears in 5 of 27 entries (e.g., Captain T Cell and Azure Biosystems in 2025), and “undisclosed” amounts appear in 7 of 27 entries (e.g., LASO Biotech on 2025-11-27).
Do any countries or cities appear disproportionately across these 27 rows?
The US is prominent in the geographic mix, with multiple distinct metro areas showing up (e.g., Boston: Modulight Bio on 2025-11-12; San Francisco: Expedition Therapeutics on 2025-10-09; New York: NILO Therapeutics on 2025-10-08; Philadelphia: BlueWhale Bio on 2025-10-19). Europe/Asia also contribute major entries such as GRIT Biotechnology (Shanghai, Series C $84M on 2025-10-19) and AAVantgarde Bio (Milano, Series B $141M on 2025-11-03).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.